TY - JOUR T1 - Use and impact of the prehospital 12-lead ECG in the primary PCI era (PHECG2): protocol for a mixed-method study JF - Open Heart JO - Open Heart DO - 10.1136/openhrt-2019-001156 VL - 6 IS - 2 SP - e001156 AU - Lucia Gavalova AU - Mary Halter AU - Helen Snooks AU - Chris P Gale AU - Clive Weston AU - Alan Watkins AU - Scott Munro AU - Glenn Davies AU - Chelsey Hampton AU - Timothy Driscoll AU - Andy Rosser AU - Nigel Rees AU - Sarah Black AU - Tom Quinn Y1 - 2019/11/01 UR - http://openheart.bmj.com/content/6/2/e001156.abstract N2 - Introduction Use of the prehospital 12-lead ECG (PHECG) is recommended in patients presenting to emergency medical services (EMS) with suspected acute coronary syndrome (ACS). Prior research found that although PHECG use was associated with improved 30-day survival, a third of patients (typically women, the elderly and those with comorbidities) under EMS care did not receive a PHECG.The overall aim of the PHECG2 study is to update evidence on care and outcomes for patients eligible for PHECG, specifically addressing the following research questions: (1) Is there a difference in 30-day mortality, and in reperfusion rate, between those who do and those who do not receive PHECG? (2) Has the proportion of eligible patients who receive PHECG changed since the introduction of primary percutaneous coronary intervention networks? (3) Are patients that receive PHECG different from those that do not in terms of social and demographic factors, or prehospital clinical presentation? (4) What factors influence EMS clinicians’ decisions to perform PHECG?Methods and analysis This is an explanatory, mixed-method study comprising four work packages (WPs). WP1 is a population-based, linked-data analysis of a national ACS registry (Myocardial Ischaemia National Audit Project). WP2 is a retrospective chart review of patient records from three large regional EMS. WP3 comprises focus groups of EMS personnel. WP4 will synthesise findings from WP1–3 to inform the development of an intervention to increase PHECG uptake.Ethics and dissemination The study has been approved by the London-Hampstead Research Ethics Committee (ref: 18LO1679). Findings will be disseminated through feedback to participating EMS, conference presentations and publication in peer-reviewed journals.Trial registration number NCT03699137 ER -